{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:45:27Z","timestamp":1791193527072,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008817","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,5,31]],"date-time":"2013-05-31T00:00:00Z","timestamp":1369958400000}}],"reference-count":72,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008817.pub2","type":"journal-article","created":{"date-parts":[[2013,5,28]],"date-time":"2013-05-28T13:42:16Z","timestamp":1369748536000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients"],"prefix":"10.1002","volume":"2013","author":[{"given":"Luit","family":"Penninga","sequence":"first","affiliation":[{"name":"Rigshospitalet, Copenhagen University Hospital; Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth I","family":"Penninga","sequence":"additional","affiliation":[{"name":"Bispebjerg Hospital; Department of Clinical Pharmacology; Bispebjerg Bakke 23 Copenhagen Denmark DK-2400"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian H","family":"M\u00f8ller","sequence":"additional","affiliation":[{"name":"Rigshospitalet, Copenhagen University Hospital; Department of Cardiothoracic Surgery, RT 2152; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Iversen","sequence":"additional","affiliation":[{"name":"Rigshospitalet, Copenhagen University Hospital; Medical Department B-2142, Division of Lung Transplantation; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A","family":"Steinbr\u00fcchel","sequence":"additional","affiliation":[{"name":"Rigshospitalet, Copenhagen University Hospital; Department of Cardiothoracic Surgery, RT 2152; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,5,31]]},"reference":[{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD008817.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/j.healun.2005.11.248","article-title":"A prospective randomized study of tacrolimus versus cyclosporine after lung transplantation","volume":"25","author":"Hachem","year":"2006","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD008817.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.healun.2007.07.027","article-title":"A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation","volume":"26","author":"Hachem","year":"2007","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD008817.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1016\/j.healun.2007.11.414","article-title":"Complete 3 year analysis of a prospective randomized international multi-center investigator driven study comparing tacrolimus and cyclosporin A, both in combination with MMF and steroids after lung transplantation in 249 patients [abstract]","volume":"27","author":"Reichenspurner","year":"2008","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD008817.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.healun.2004.11.144","article-title":"One year complete follow-up of a prospective randomized international investigator driven study comparing Tac and CsA (+MMF\/steroids) after lung transplantation in 274 patients [abstract]","volume":"24","author":"Reichenspurner","year":"2005","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD008817.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S1053-2498(02)00686-1","article-title":"Prospective randomized international multi-center investigator driven study comparing Tac and CsA (+MMF\/steroids) after lung transplantation - interim analysis of 110 patients [abstract]","volume":"22","author":"Reichenspurner","year":"2003","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD008817.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1016\/j.healun.2006.11.442","article-title":"Final 3 year analysis of a prospective randomized international multicenter investigator driven study comparing Tac and CsA (+ MMF\/steroids) after lung transplantation in 274 patients [abstract]","volume":"26","author":"Reichenspurner","year":"2007","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD008817.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.healun.2009.11.107","article-title":"Risk of bronchiolitis obliterans syndrome is twice as high in cyclosporine treated patients in comparison to tacrolimus 3 years after lung transplantation: Results of a prospective randomized international trial of 248 patients","volume":"29","author":"Treede","year":"2010","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD008817.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.healun.2012.03.008","article-title":"Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: Results of a prospective, randomized international trial in lung transplantation","volume":"31","author":"Treede","year":"2012","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008817.pub2-BIB0009|cit9","first-page":"54","article-title":"Tacrolimus reduces the risk for bronchiolitis obliterans syndrome 3 years after lung-transplantation by 50% in comparison to cyclosporine in a prospective randomized international trial of 248 patients","volume":"22","author":"Treede","year":"2009","journal-title":"Transplant International"},{"issue":"1","key":"10.1002\/14651858.CD008817.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1053-2498(99)80046-1","article-title":"Prospective randomized two-center trial comparing cyclosporine A (CsA) versus tacrolimus (Tac), in combination with mycophenolate mofetil (MMF) and steroids after lung transplantation (LTX) [abstract]","volume":"18","author":"Klepetko","year":"1999","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD008817.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S1053-2498(01)00244-3","article-title":"Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols","volume":"20","author":"Treede","year":"2001","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD008817.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1067\/mtc.2003.71","article-title":"Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial","volume":"125","author":"Zuckermann","year":"2003","journal-title":"Journal of Thoracic & Cardiovascular Surgery"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD008817.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/S1053-2498(02)00685-X","article-title":"Long term follow-up of a prospective randomized trial comparing tacrolimus versus cyclosporine in combination with MMF after lung transplantation","volume":"22","author":"Zuckermann","year":"2003","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD008817.pub2-BIB0014|cit14","first-page":"B13","article-title":"A comparison of three tacrolimus based immunosuppressive regimens in lung transplantation","volume":"165","author":"Bhorade","year":"2002","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD008817.pub2-BIB0015|cit15","first-page":"3017","article-title":"FK 506 in solid organ transplantation","volume":"26","author":"Fung","year":"1994","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD008817.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/00007890-199403270-00013","article-title":"A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation","volume":"57","author":"Griffith","year":"1994","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD008817.pub2-BIB0017|cit17","first-page":"58","article-title":"Long term follow up clinical trial of tacrolimus versus cyclosporin for lung transplantation","volume":"17","author":"Keenan","year":"1998","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD008817.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0003-4975(95)00407-C","article-title":"Clinical trial of tacrolimus versus cyclosporine in lung transplantation","volume":"60","author":"Keenan","year":"1995","journal-title":"Annals of Thoracic Surgery"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD008817.pub2-BIB0019|cit19","first-page":"159","article-title":"Long term follow-up of a prospective, randomized trial of tacrolimus versus cyclosporine in human lung transplantation [abstract]","volume":"2","author":"McCurry","year":"2002","journal-title":"American Journal of Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD008817.pub2-BIB0020|cit20","first-page":"905","article-title":"Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome","volume":"16","author":"Kesten","year":"1997","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD008817.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-2007-1013136","article-title":"Tacrolimus (FK506) as primary immunosuppressant after lung transplantation","volume":"47","author":"Kur","year":"1999","journal-title":"Thoracic & Cardiovascular Surgeon"},{"key":"10.1002\/14651858.CD008817.pub2-BIB0022|cit22","first-page":"S90","article-title":"Comparative study between cyclosporin and tacrolimus in immune suppression after lung transplantation","volume":"54","author":"Schwaiblmair","year":"2000","journal-title":"Pneumologie"},{"issue":"10","key":"10.1002\/14651858.CD008817.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.healun.2009.08.002","article-title":"Registry of the International Society for Heart and Lung Transplantation: Twelfth Official Pediatric Lung and Heart\/Lung Transplantation Report-2009","volume":"28","author":"Aurora","year":"2009","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD008817.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-2277.2000.tb01004.x","article-title":"Neurotoxicity of calcineurin inhibitors: impact and clinical management","volume":"13","author":"Bechstein","year":"2000","journal-title":"Transplant International"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD008817.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"442S","DOI":"10.1016\/j.transproceed.2004.01.004","article-title":"History of C2 monitoring in heart and liver transplant patients treated with cyclosporine microemulsion","volume":"36","author":"Cantarovich","year":"2004","journal-title":"Transplantation Proceedings"},{"issue":"10","key":"10.1002\/14651858.CD008817.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.healun.2009.08.004","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report-2009","volume":"28","author":"Christie","year":"2009","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD008817.pub2-BIB0027|cit27","first-page":"713","article-title":"A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation","volume":"12","author":"Cooper","year":"1993","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD008817.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1399-0012.2009.00963.x","article-title":"Conversion to sirolimus with calcineurin inhibitor elimination vs. dose minimization and renal outcome in heart and lung transplant recipients","volume":"23","author":"Demirjian","year":"2009","journal-title":"Clinical Transplantation"},{"issue":"13","key":"10.1002\/14651858.CD008817.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2165\/00003495-200161130-00006","article-title":"Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral \u00ae) in organ transplantation","volume":"61","author":"Dunn","year":"2001","journal-title":"Drugs"},{"issue":"7109","key":"10.1002\/14651858.CD008817.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD008817.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.transproceed.2008.11.016","article-title":"Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis","volume":"41","author":"Fan","year":"2009","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD008817.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0012.2007.00739.x","article-title":"Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity","volume":"22","author":"Flechner","year":"2008","journal-title":"Clinical Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD008817.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/aje\/kwj069","article-title":"Bias in clinical intervention research","volume":"163","author":"Gluud","year":"2006","journal-title":"American Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD008817.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1600-6143.2003.00372.x","article-title":"New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis","volume":"4","author":"Heisel","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD008817.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD008817.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008817.pub2-BIB0037|cit37","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"8","key":"10.1002\/14651858.CD008817.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.healun.2008.05.018","article-title":"Tacrolimus treatment effectively inhibits progression of obliterative airway disease even at later stages of disease development","volume":"27","author":"Hollmen","year":"2008","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD008817.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MOT.0b013e32831040bf","article-title":"Evidence for immunosuppression in lung transplantation","volume":"13","author":"Hopkins","year":"2008","journal-title":"Current Opinion in Organ Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD008817.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1164\/ajrccm.159.3.9607099","article-title":"Analysis of risk factors for the development of bronchiolitis obliterans syndrome","volume":"159","author":"Husain","year":"1999","journal-title":"American Journal of Respiratory & Critical Care Medicine"},{"key":"10.1002\/14651858.CD008817.pub2-BIB0041|cit41","unstructured":"European Medicines Agency Guideline for good clinical practice. E6 (R1) http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500002874.pdf (accessed February 2013)"},{"key":"10.1002\/14651858.CD008817.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1183\/1025448x.00045012","article-title":"Immunosuppression","volume-title":"European respiratory monographs: lung transplantation","author":"Iversen","year":"2009"},{"issue":"9","key":"10.1002\/14651858.CD008817.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.healun.2009.05.022","article-title":"Cyclosporine C2 levels have impact on incidence of rejection in de novo lung but not heart transplant recipients: the NOCTURNE study","volume":"28","author":"Iversen","year":"2009","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD008817.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/S0041-1345(99)00235-3","article-title":"Differences between cyclosporin A and tacrolimus in organ transplantation","volume":"31","author":"Jiang","year":"1999","journal-title":"Transplantation Proceedings"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD008817.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"378S","DOI":"10.1016\/j.transproceed.2004.01.091","article-title":"Therapeutic drug monitoring of cyclosporine: 20 years of progress","volume":"36","author":"Kahan","year":"2004","journal-title":"Transplantation Proceedings"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD008817.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/j.transproceed.2004.01.018","article-title":"Pharmacology of calcineurin antagonists","volume":"36","author":"Kapturczak","year":"2004","journal-title":"Transplantation Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD008817.pub2-BIB0047|cit47","first-page":"546","article-title":"Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials","volume":"104","author":"Keus","year":"2009","journal-title":"American Journal of Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD008817.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD008817.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1016\/S0041-1345(98)01123-3","article-title":"Estimation of mean relative bioavailability of cyclosporine Sandimmune and Neoral using NONMEM in renal transplant recipients","volume":"30","author":"Lee","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD008817.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"20","author":"Macaskill","year":"2001","journal-title":"Statistics in Medicine"},{"issue":"7","key":"10.1002\/14651858.CD008817.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.1600-6143.2006.01360.x","article-title":"Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis","volume":"6","author":"McAlister","year":"2006","journal-title":"American Journal of Transplantation"},{"issue":"9128","key":"10.1002\/14651858.CD008817.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD008817.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"issue":"10","key":"10.1002\/14651858.CD008817.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2165\/00002018-200124100-00004","article-title":"Calcineurin inhibitors and post-transplant hyperlipidaemias","volume":"24","author":"Moore","year":"2001","journal-title":"Drug Safety"},{"issue":"12","key":"10.1002\/14651858.CD008817.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00228-010-0902-6","article-title":"Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials","volume":"66","author":"Penninga","year":"2010","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD008817.pub2-BIB0056|cit56","first-page":"1002","article-title":"Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience","volume":"28","author":"Pham","year":"1996","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"10.1002\/14651858.CD008817.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.healun.2004.02.022","article-title":"Overview of tacrolimus-based immunosuppression after heart or lung transplantation","volume":"24","author":"Reichenspurner","year":"2005","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"34","key":"10.1002\/14651858.CD008817.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"iii, ix-51","DOI":"10.3310\/hta7340","article-title":"Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system","volume":"7","author":"Royle","year":"2003","journal-title":"Health Technology Assessment"},{"issue":"5","key":"10.1002\/14651858.CD008817.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD008817.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2165\/00003495-200767110-00002","article-title":"Immunosuppression for lung transplantation: evidence to date","volume":"67","author":"Snell","year":"2007","journal-title":"Drugs"},{"issue":"8670","key":"10.1002\/14651858.CD008817.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(89)91014-3","article-title":"FK 506 for liver, kidney, and pancreas transplantation","volume":"2","author":"Starzl","year":"1989","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD008817.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"10","key":"10.1002\/14651858.CD008817.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"e25491","DOI":"10.1371\/journal.pone.0025491","article-title":"The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis - a simulation study","volume":"6","author":"Thorlund","year":"2011","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD008817.pub2-BIB0064|cit64","unstructured":"Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C Thorlund K User manual for trial sequential analysis (TSA). Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Denmark Available from www.ctu.dk\/tsa 2011 1 115"},{"key":"10.1002\/14651858.CD008817.pub2-BIB0065|cit65","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for trial sequential analysis (TSA). Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Denmark Available from www.ctu.dk\/tsa 2011"},{"issue":"6","key":"10.1002\/14651858.CD008817.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus","volume":"7","author":"Vincenti","year":"2007","journal-title":"American Journal of Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD008817.pub2-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003961.pub2","article-title":"Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients","author":"Webster","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7520","key":"10.1002\/14651858.CD008817.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bmj.38569.471007.AE","article-title":"Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data","volume":"331","author":"Webster","year":"2005","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD008817.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008817.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"7","key":"10.1002\/14651858.CD008817.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.healun.2004.05.023","article-title":"Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: The Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion","volume":"24","author":"White","year":"2005","journal-title":"Journal of Heart & Lung Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD008817.pub2-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008817","article-title":"Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients","author":"Penninga","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD008817.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T08:46:34Z","timestamp":1750754794000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008817.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,31]]},"references-count":72,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008817.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,31]]}}}